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Abstract
The ratio of the index (2nd) finger to ring (4th) finger lengths (2D:4D) is a proxy for fetal 
testosterone and estradiol. Studies suggesting 2D:4D is inversely associated with autism spectrum 
disorder (ASD) in males were limited by lack of confounder and subgroup assessments. Studies of 
females are sparse. We examined associations between ASD and 2D:4D among children in the 
Study to Explore Early Development; we considered case subgroups and numerous potential 
demographic and maternal-perinatal health confounders. We observed a modest inverse 
association between ASD and right-hand 2D:4D in males; subgroup analyses indicated 
associations were limited to ASD cases with birth defects/genetic syndromes or dysmorphic 
features. We observed a positive association between ASD and left-hand 2D:4D in females, overall 
and within most case subgroups.
Keywords
Autism spectrum disorder; Testosterone; Estradiol; Fetal development
Correspondence to: Laura A. Schieve.
Disclaimer The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of 
the Centers for Disease Control and Prevention.
Author Contributions LAS made substantial contributions to acquisition of data, study conception and design, analysis and 
interpretation of data, drafting the article, revising the article critically for important intellectual content, and gave final approval of the 
version to be published. LT made substantial contributions to study conception and design, analysis and interpretation of data, revising 
the article critically for important intellectual content, and gave final approval of the version to be published. ND, LC, JH-F, AA and 
SKS made substantial contributions to acquisition of data, study conception and design, interpretation of data, revising the article 
critically for important intellectual content, and gave final approval of the version to be published.
Compliance with Ethical Standards
Ethical Approval All procedures performed in studies involving human participants were in accordance with the ethical standards of 
the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable 
ethical standards.
Informed Consent Informed consent was obtained from all participants in this study.
Conflict of interest All authors report no conflicts of interest for this study.
HHS Public Access
Author manuscript
J Autism Dev Disord. Author manuscript; available in PMC 2019 July 01.
Published in final edited form as:














Autism spectrum disorder (ASD) is a pervasive neurodevelopmental condition estimated to 
occur in 1–2% of children (Christensen et al. 2016; Blumberg et al. 2013). The defining 
characteristics of ASD include social and communication deficits and restricted stereotyped 
patterns of behavior. Population prevalence studies indicate a marked male:female sex ratio 
with the ASD prevalence 4–5 times higher in males than females (Christensen et al. 2016; 
Blumberg et al. 2013).
While much remains unknown about the underlying causes of ASD, available evidence 
strongly indicates it has a complex, multifactorial etiology with involvement of both genetic 
and environmental factors (Miles 2011; Kim and Leventhal 2015; Ornoy et al. 2016; Arndt 
et al. 2005). Studies also implicate the prenatal period as the critical window of exposure 
(Arndt et al. 2005). Given the core neurodevelopmental features and marked male 
predominance of ASD, one etiologic hypothesis put forth by Baron-Cohen and colleagues 
(2011) is the “Extreme Male Brain” (EMB) theory. EMB theory asserts that individuals with 
ASD have a very high systemizing drive and very low empathizing drive, which is caused by 
exposure to high concentrations of testosterone during fetal development.
Fetal testosterone has been linked to neurodevelopment in both animal and human studies. 
Animal studies demonstrate that exposure to high concentrations of testosterone can impact 
brain structure, cognition, and behavior (Taylor et al. 2017; Jacome et al. 2016; Hu et al. 
2015; Dela Cruz and Pereira 2012; Thornton et al. 2009). Human studies, which necessarily 
examined fetal testosterone concentrations within a more limited range (i.e., the typical 
range of prenatal variability), are also suggestive of impacts on neurodevelopment, including 
several traits related to ASD. These include inverse associations between amniotic 
testosterone concentration and eye contact at 12 months (Lutchmaya et al. 2002a) and 18 
months (Saenz and Alexander 2013), vocabulary size at 18–24 months (Lutchmaya et al. 
2002b), social cognition at 4 years (Knickmeyer et al. 2005) and level of empathy at 4 and 8 
years (Chapman et al. 2006; Knickmeyer et al. 2006) and positive associations between 
amniotic testosterone and non-social domains, such as restricted interests, at 4 years 
(Knickmeyer et al. 2005). Additionally, a recent study demonstrated that amniotic levels of 
several steroidal hormones, including testosterone, were elevated in individuals who went on 
to develop ASD (Baron-Cohen et al. 2015).
Other studies have assessed associations between the ratio of the length of the index finger 
(2nd digit) to the ring finger (4th digit) (2D:4D) as a proxy for fetal testosterone 
concentration. In utero development of the metacarpals and phalangeal bones of the hands 
are regulated by the same HOX cluster genes that regulate development of the male 
reproductive tract, as evidenced by mutations in HOXA13 and HOXD13 causing hand-foot-
genital syndrome (Quinonez and Innis 2014). These genes respond to circulating androgens 
(Kondo et al. 1997; Manning and Bundred 2000; Zheng and Cohn 2011). Specifically, fetal 
testosterone stimulates elongation of the 4th digit relative to the 2nd digit, such that the 2D:
4D is inversely associated with fetal testosterone concentration. Additionally there is a 
suggestion that 2D:4D may be positively associated with fetal estradiol concentration and 
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inversely associated with the ratio of fetal testosterone to estradiol (Manning et al. 1998; 
Lutchmaya et al. 2004).
Given the difficulty in obtaining amniotic specimens, 2D:4D is a key proxy for fetal 
testosterone and possibly fetal estradiol concentrations. The validity of 2D:4D as a proxy is 
supported by limited direct empiric evidence (Lutchmaya et al. 2004; Ventura et al. 2013) 
and indirect evidence of observed inverse associations between 2D:4D and both male sex 
(McIntyre 2006; Manning and Bundred 2000; Zheng and Cohn 2011; Ventura et al. 2013) 
and congenital adrenal hyperplasia among females (McIntyre 2006). While limited, the 
available evidence generally supports that 2D:4D is likely a superior proxy to other biologic 
measurements, such as umbilical cord or gravid maternal serum testosterone concentrations, 
which have both been found to be poorly correlated with fetal amniotic testosterone 
concentrations at critical periods of development (McIntyre 2006; van de Beek et al. 2004).
The findings from studies examining associations between 2D:4D and ASD have been 
inconsistent. While most studies of male samples (Al-Zaid et al. 2015; Masuya et al. 2015; 
Krajmer et al. 2011; de Bruin et al. 2006) or samples in which the vast majority of 
participants were male (Noipayak 2009; Sugie et al. 2010; Milne et al. 2006; Manning et al. 
2001) have reported inverse associations between 2D:4D and ASD diagnosis, other studies 
of males reported no association between 2D:4D and ASD diagnosis (Falter et al. 2008) or 
reported a positive association (Bejerot et al. 2012). A related study reported no association 
between 2D:4D and scores on standardized assessments of autistic traits in males (Barona et 
al. 2015); however, in that study, the authors did observe an inverse association in post hoc 
analyses examining the most extreme digit ratio measure—digit ratio in the lowest 10th 
percentile (Barona et al. 2015).
Even among studies showing an association, there were inconsistencies and limited data. 
Among eight studies reporting inverse associations between ASD or autistic traits and 2D:
4D in male or nearly-all male samples, two reported associations with right-hand 2D:4D but 
not left-hand (Barona et al. 2015; Masuya et al. 2015); two reported associations with both 
hands (Noipayak 2009; de Bruin et al. 2006); two assessed right hand only (Al-Zaid et al. 
2015; Sugie et al. 2010); and two assessed the average of right hand 2D:4D and left-hand 
2D:4D but did not present separate results for each hand (Milne et al. 2006; Manning et al. 
2001). The study reporting a positive association between ASD and 2D:4D reported similar 
results for both hands (Bejerot et al. 2012). A meta-analysis that included several of the 
aforementioned studies reported a significant inverse association between ASD and right-
hand 2D:4D but not left hand (Teatero and Netley 2013).
There is a paucity of studies examining associations between ASD and 2D:4D in females. 
Of the limited studies that separately assessed samples of females, results have been 
inconsistent; one found no association between ASD and 2D:4D of either hand (Bejerot et 
al. 2012), one showed no association between autistic traits and 2D:4D of either hand 
(Barona et al. 2015), and one showed a positive association between ASD and right-hand 
2D:4D but no association with left-hand 2D:4D (Masuya et al. 2015).
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Digit ratio studies among both males and females must be interpreted in context of several 
important methodologic limitations. The majority of studies included small samples of 
children or adults (< 100 ASD cases) recruited from clinics, schools, or ASD support 
organizations with varying methods and rigor in defining ASD. Assessment of potential 
confounding factors was very limited. Only one study (of autistic traits as measured on the 
Social Communication Questionnaire) adjusted for sociodemographic factors; and none of 
the studies to date considered other important biologic pregnancy exposures that might 
influence fetal testosterone and/or estradiol concentrations. Although data are limited or not 
available on direct fetal testosterone effects in humans, and as noted above umbilical cord 
and maternal prenatal testosterone levels are not necessarily reflective of fetal testosterone 
exposure, numerous maternal and perinatal factors should nonetheless be investigated as 
potential confounders given there has been some suggestion of an association with either 
fetal or maternal testosterone or estradiol concentrations. These include maternal smoking in 
pregnancy (Rizwan et al. 2007; Toriola et al. 2011), maternal infertility conditions, such as 
polycystic ovarian syndrome (Dumesic et al. 2014; Makieva et al. 2014; Abbott et al. 2012), 
conception after ovarian stimulation treatments (Järvelä et al. 2014), prenatal progesterone 
treatments (Pointis et al. 1987), advanced maternal age (Toriola et al. 2011), parity (Toriola 
et al. 2011), race-ethnicity (Knickmeyer et al. 2011), preterm birth (Makieva et al. 2014) and 
multiple gestation pregnancy (Kuijper et al. 2015). Finally, ASD represents a spectrum of 
severity levels and often co-occurs with other conditions, including many genetic syndromes 
and birth defects (Ornoy et al. 2016); it is important to assess whether associations between 
ASD and 2D:4D are uniform across various ASD subtypes or are specific to a particular 
subset of children with ASD. These findings might provide clues as to the underlying 
explanation for the observed digit ratio associations.
The Study to Explore Early Development (SEED) (Schendel et al. 2012; Wiggins et al. 
2015a) provides a unique opportunity to more fully assess associations between ASD and 
2D:4D than has been achieved in other studies. SEED has much larger sample sizes of both 
males and females than nearly all past studies. Additionally, it was designed to enroll 
individuals from diverse population subgroups and included systematic recruitment of ASD 
cases and population controls. SEED case classification was based on rigorous research-
reliable developmental assessments conducted in person. Moreover, data on various facets of 
ASD phenotype, including data from an in depth dysmorphology assessment, were 
collected, which allowed for ASD subgroup analyses. Finally, SEED included detailed data 
collection of maternal health conditions before and during pregnancy and maternal 
exposures and behaviors during pregnancy, allowing for assessment of and control for other 
factors (beyond ASD) that might be associated with fetal testosterone and estradiol 
concentrations and thus, impact a child’s 2D:4D.
Methods
SEED was implemented in 2007 in six sites located in California, Colorado, Georgia, 
Maryland, North Carolina, and Pennsylvania. Institutional review boards at CDC and each 
study site approved the SEED protocol.
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Details of the SEED methodology were previously published (Schendel et al. 2012). Each 
site followed a common protocol, including enrollment of three study groups: children with 
ASD, children with other non-ASD developmental disabilities (DD group), and non-ASD 
children from the general population (POP group). Children for the ASD and DD groups 
were identified from multiple special education and clinical sources that provide services to 
children with disabilities. Children recruited from each source were those with select special 
education or International Classification of Diseases codes indicative of autism/ASD or 
other DDs often seen as precursors or co-occurring diagnoses in children eventually 
diagnosed with ASD. POP children were selected from random samples of the birth 
certificates within a given site’s defined geographic study area.
Recruitment, enrollment, and data collection activities for the first phase of SEED occurred 
from 2007 to 2012. Eligible children were born between 2003 and 2006, lived in the 
respective site’s study area both at birth and at study enrollment, and lived with a caregiver 
since 6 months of age who could provide legal consent and was capable of communicating 
in English (all sites) or Spanish (two sites). For 98% of children, the caregiver was the 
biological mother. Children were enrolled when they were 2–5 years of age. Across sites, 
22% of the potential ASD or DD families who were contacted were found to be ineligible, 
34% refused participation before eligibility could be determined, and 43% were eligible and 
enrolled. Among potential POP families contacted, 34% were ineligible, 40% refused before 
eligibility could be determined, and 25% were eligible and enrolled (Schendel et al. 2012).
Case identification and classification were key strengths of SEED. As described above, case 
finding included identification of young children with a range of developmental delays from 
numerous sources serving diverse population subgroups, thus casting a “wide net” to 
identify possible ASD cases (including yet undiagnosed cases) and a second non-ASD DD 
case group. Final case classification was based on in-depth standardized in-person 
developmental assessments administered by research-reliable clinical study staff, rather than 
reports of past diagnoses.
Thus, although children were initially identified as potentially being eligible for a given 
group—ASD, DD, or POP—the final study group classification was determined from 
standardized research developmental assessments (Schendel et al. 2012; Wiggins et al. 
2015a). Upon enrollment, caregivers of all children were administered the Social 
Communication Questionnaire (SCQ) to screen for possible autism characteristics in their 
children. Children with SCQ scores above the predetermined threshold of 11 were 
designated as potential ASD cases regardless of how they were initially identified. This 
threshold was intentionally set low to maximize case-finding. Additionally, all children who 
had a previous ASD diagnosis or autism special education classification were designated as 
potential ASD cases regardless of their SCQ scores. Children in the potential ASD group 
were additionally administered the Autism Diagnostic Observation Schedule (ADOS) and 
their caregivers were administered the Autism Diagnostic Interview—Revised (ADI-R). 
Final ASD case classification was based on the ADOS and ADI-R scores. Children who had 
been designated as potential ASD cases, who did not meet the criteria for classification as an 
ASD case after the ADOS and ADI-R, received a final classification of either DD or POP 
depending on their original identification source (education/clinical source vs. birth 
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certificate sample, respectively). Among the children classified as ASD cases, 85% were 
identified from special education or clinical sources and had a previous ASD diagnosis, 14% 
were identified from special education or clinical sources in which they were being served 
for another DD, and 1% were initially identified from random samples of birth certificate. 
Among children with a final classification of POP, 94% screened negative on the SCQ for 
autism characteristics and the remaining 6% screened positive for autism characteristics but 
did not meet case classification criteria on the ADOS and ADI-R. (See Wiggins et al. 2015a 
for further detail.)
A wealth of data was collected from all study groups over the course of several months. Data 
collection included an extensive telephone interview with the caregiver about family socio-
demographics and, if the caregiver was the biological mother, her reproductive history and 
information about her pregnancy with the index child. Caregivers were also asked to 
complete self-administered forms on maternal, paternal, and child health history and child 
development. All children were also seen in person for a developmental assessment and 
collection of biosamples. Additionally, at this visit or a separate second in person visit, a 
detailed dysmorphology examination was conducted on all children; this included scanned 
images of both hands (“hand scans”) obtained using research reliable methods (see below). 
Study personnel (dysmorphology aides) at each site were trained by a clinical geneticist to 
perform a standardized dysmorphology protocol and dysmorphology aides were supervised 
by an on-site clinician. The dysmorphology protocol consisted of six parts: (1) in-person 
height, weight, and head circumference measurements of the child; (2) in-person 
standardized examination of the child by visual inspection and under Woods lamp; (3) 
obtaining a standard series of photographs of the child, along with additional photographs of 
unusual findings; (4) obtaining hand scans of both hands; (5) filling out a standardized 
Dysmorphology Examination Form with the collected data observations from the 
examination; and (6) following the in-person evaluation, performing a set of measurements 
from photographs and hand scans, recording those measurements on the Dysmorphology 
Exam Form, and determining and recording percentiles for all measurements obtained. Each 
site also compiled and submitted analytic variables from children’s birth certificates.
Sample Selection
This analysis is limited to children who completed the study and received a final case 
classification of ASD or POP. We did not include children with a final classification of DD 
because due to resource constraints, we did not complete assessments important to this study 
for this group of children. Additionally, we excluded children who did not have hand scans 
taken (~ 12% of the sample of ASD and POP children); most of these children did not have 
hand scans because image scanning equipment was not available at the time of the 
examination. One additional child’s right-hand data were excluded because the calculated 
digit ratio (0.67) was considered outside the valid range.
2D:4D Digit Ratio
Study staff at each SEED site were trained in performing hand scans of children using a 
common protocol and a color scanner with a minimum resolution of 3200 dpi. The protocol 
described how a child’s hands were to be placed on the scanner next to a sticker or a flat 
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plastic ruler of a standard length (internal measurement). If a child was not able to place his 
or her hands completely flat on the scanner, study staff, often with the assistance of a family 
member, held the child’s palms and digits flat on the scanner bed, typically by placing their 
adult hand over the child’s and pressing evenly over the course of scanning the hand. Most 
children, regardless of the study group, needed at least light reassuring pressure of an adult’s 
hands resting on and positioning the child’s hands so that they lay completely flat on the 
scanner bed. Digital images from the hand scans were analyzed by study staff at each SEED 
site, trained in using FAS Facial Photographic Analysis Software (http://
depts.washington.edu/fasdpn/htmls/order-forms.htm) to measure the following hand 
structures on both hands and compare those measurements to the internal standard to obtain 
and record actual measurements: second digit length, third digit length, fourth digit length, 
palm length, and total hand length.
In order to maintain quality control for hand scan measurements across the six SEED sites, 
every month a common set of hand scan images was distributed to study staff at each site 
responsible for measuring digit length from hand scans. Two study staff at the Georgia 
SEED site, both skilled in obtaining digit measurements, would calculate the digit lengths 
and agree on a reliable measurement for each digit. Study staff at the other five SEED sites 
would independently perform the same digit measurements and submit the values for 
comparison to the Georgia SEED standard. Measurements could not differ from the standard 
by more than 5%. Study staff who did not achieve the concordance threshold were retrained 
in obtaining measurements and retested for reliability with Georgia SEED standard 
measurements.
Previous studies that have assessed the validity of using 2D:4D measures based on hand 
scans vs direct measurement reported good agreement between the two (Barona et al. 2015; 
Manning et al. 2001).
Confounders
We considered the following variables as potential confounders or effect modifiers: child 
sex, child race-ethnicity, child age at scan, birth order, maternal age at birth, maternal 
education at birth, maternal pre-pregnancy body mass index (BMI), maternal diagnosis of an 
infertility disorder prior to the index pregnancy, use of ovulation stimulation medications to 
achieve the index pregnancy, use of progesterone just before or during pregnancy, maternal 
smoking during pregnancy, preterm delivery, and multiple-gestation pregnancy.
Statistical Analyses
Given the established differences in testosterone and estradiol concentrations in pregnancies 
with male and female fetuses, we conducted all analyses separately for males and females. 
We calculated mean 2D:4D for both left and right hands and the mean difference between 
ASD and POP children for left- and right-hand digit ratios separately. We calculated 
adjusted ASD–POP differences in mean left- and right-hand 2D:4D from ANOVA models 
that included child race-ethnicity, child age at hand scan, birth order, maternal age and 
education at birth, and maternal pre-pregnancy BMI. We did not include all potential 
confounding factors in ANOVA models because of the instability of some models when all 
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factors were included, particularly among females, due to small sample sizes for certain 
subgroups. Rather, we assessed the impact of certain maternal and perinatal factors that 
pertained to a relatively small percentage of children in our sample through a series of 
analyses whereby we restricted our sample to exclude children with a given factor: preterm 
delivery, multiple-gestation pregnancy, prepregnancy maternal infertility disorder, use of 
ovulation stimulation medications for pregnancy conception, use of progesterone before or 
during pregnancy, and smoking during pregnancy. We conducted analyses in which we 
excluded children with each factor separately and in a sample in which we excluded children 
with any of the above factors (referred heretofore as the “complete restricted sample”). We 
assessed both unadjusted and adjusted mean digit ratio differences for the complete 
restricted sample.
In addition to our overall case-control comparisons, we conducted the same set of analyses 
for ASD subgroups compared to the full POP control group. We divided our male and 
female case samples into three sub-groupings: whether or not the child had intellectual 
disability (ID) in addition to ASD; whether or not the child had a birth defect, Down 
syndrome, fragile X syndrome, Rett syndrome, or tuberous sclerosis diagnosis in addition to 
ASD; and whether or not the child met SEED study criteria for classification as dysmorphic. 
Intellectual disability was defined as a score < 70 on the Mullen Scales of Early Learning 
(MSEL) cognitive scales. Birth defects and genetic conditions were ascertained via maternal 
report of diagnoses from a healthcare provider. Children were classified as dysmorphic or 
non-dysmorphic based on comprehensive standard assessment of 397 individual physical 
features by expert clinical geneticists (Shapira et al. 2015). Sample sizes for these analyses 
were reduced to varying extents relative to the sample sizes for the total ASD–POP 
comparisons because of missing values for data needed to determine case subgroup: 1, 3, 
and 23% missing data for ID, birth defects/genetic diagnoses, and dysmorphology 
classifications, respectively. Due to resource constraints, dysmorphology classifications were 
not obtained on all children who participated in the study. Dysmorphology classifications 
were restricted to three racial/ethnic groups—non-Hispanic White, non-Hispanic Black, and 
Hispanic—and to participants who had completed nearly all other data collection 
components of the study. Among males in the ASD case group with non-missing data, 59% 
had ID, 6% had a birth defect or genetic disorder, and 14% were classified as dysmorphic. 
Among females in the ASD case group with non-missing data, 69% had ID, 15% had a birth 
defect or genetic disorder, and 22% were classified as dysmorphic.
In all analyses, our comparison group was the full POP sample. We designed this analysis to 
understand how 2D:4D among children in the total ASD case group and each case subgroup 
compared to expectations based on a general population referent. We did not exclude from 
the POP group children with low MSEL scores, maternal report of birth defects or genetic 
conditions, or dysmorphic features. A previous analysis confirmed that the final POP sample 
for SEED was developmentally representative of children in the general population. Mean 
scores on the MSEL indicated average cognitive ability, internalizing and externalizing 
behavioral problems were infrequent, and mothers reported very few specific developmental 
diagnoses (see Wiggins et al. 2015b). Additionally, in our study sample for this analysis only 
2% of POP group children met the criteria for ID, 3% had a birth defect or genetic condition, 
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and 5% met our criteria for dysmorphic. Each of these proportions is in line with 
expectations for U.S. children generally.
For all analyses of means, statistical significance of differences in mean 2D:4D were 
assessed with t-tests for unadjusted analyses, and f-tests for adjusted analyses.
For males, we also assessed a binary variable for digit ratio difference in the most extreme 
end of the distribution, i.e., the lowest 10th percentile. We defined lowest 10th percentile 
based on distribution in the composite ASD + POP sample. We calculated adjusted odds 
ratios (aOR) for associations between ASD and 2D:4D < 10th percentile from logistic 
regression models. Confounding factors included in the model were the same as those 
included in ANOVA models. Small sample size precluded these analyses for females.
For readability, we present all measures of 2D:4D and 2D:4D difference as measure × 100.
Results
Sample Description
Our analytic sample included 599 children with ASD (592 had data on left-hand 2D:4D and 
595 had data on right-hand 2D:4D) and 811 POP controls (807 had valid data on left-hand 
2D:4D and 808 had valid data on right-hand 2D:4D). While about half (53%) of the POP 
control group were males, 81% of children in the ASD case group were males (Table 1). 
Thus, case sample size for analyses of females was much smaller (n = 112) than that for 
analyses of males (n = 487). Compared to controls, cases were more likely to have been born 
preterm or in a multiple-gestation pregnancy. They were also more likely to be non-Hispanic 
black, Hispanic or Asian. Case mothers were less likely than control mothers to have been 
35 years of age or older or to have a college education or higher at the time of their child’s 
birth; they were more likely to have had an infertility disorder, prepregnancy obesity, and to 
have smoked during pregnancy.
Assessment of Males: ASD Group Versus POP Group
Among males, the ASD–POP difference in mean left-hand 2D:4D (×100) was − 0.36 (p = 
0.162), indicating a lower 2D:4D in males with ASD compared to controls. This difference 
was attenuated after adjustment for child race-ethnicity, age at scan, maternal age at birth, 
education at birth, and pre-pregnancy BMI (− 0.21) (Table 2). In most analyses in which 
children with maternal and perinatal health factors that might have impacted fetal 
testosterone exposure were excluded, ASD–POP differences in mean left-hand 2D:4D 
ranged from − 0.25 to − 0.39 (all non-significant). However, the difference after exclusion of 
children whose mothers smoked during pregnancy (− 0.63) was statistically significant. 
Nonetheless, in the complete restricted sample (singleton term births with no maternal 
infertility disorders, no use of maternal ovulation medications or progesterone, and no 
maternal smoking during pregnancy), the ASD–POP difference in left-hand 2D:4D (− 0.50) 
was not statistically significant and as with the total sample, the difference was attenuated 
after adjustment (− 0.28).
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The ASD–POP difference in mean right-hand 2D:4D was − 0.51 (p = 0.033). This difference 
was also attenuated after adjustment (− 0.34, p = 0.172). ASD–POP differences in 2D:4D in 
restricted sample analyses ranged from − 0.43 to − 0.73 and several were statistically 
significant. Nonetheless, the difference in right-hand 2D:4D in the complete restricted 
sample (− 0.64) was attenuated after adjustment (− 0.48) and no longer reached statistical 
significance (p = 0.145).
The odds of 2D:4D < 10th percentile among male cases was similar to that of controls. The 
aORs for the association between ASD and left-hand 2D:4D < 10th percentile were 1.29 
(95% confidence interval (CI) 0.82–2.01) for the full sample and 1.28 (95% CI 0.69–2.40) 
for the complete restricted sample. The aORs for the association between ASD and right-
hand 2D:4D < 10th percentile were 1.36 (95% CI 0.85–2.19) for the full sample and 0.93 
(95% CI 0.50–1.73) for the complete restricted sample.
Assessment of Males: ASD Subgroups versus POP Group
We observed marked heterogeneity in the findings when we divided our ASD case group 
into more homogenous subgroups (Table 3). The findings for several subgroups were similar 
to those from the ASD versus POP assessments presented in Table 2. For both left- and 
right-hand analyses, we observed only small, non-significant differences in mean 2D:4D 
between POP controls and (1) children with ASD but not ID, (2) children with ASD without 
a birth defect/genetic disorder, and (3) children with non-dysmorphic ASD. The findings 
were similar in adjusted, and complete restricted sample adjusted analyses with one 
exception; the adjusted mean difference in 2D:4D for non-dysmorphic ASD versus POP 
groups (− 0.77) was statistically significant; however, this finding was greatly attenuated and 
no longer significant in the complete restricted sample.
In contrast, in both left- and right-hand analyses, we observed large and statistically 
significant differences in mean 2D:4D between children with ASD + a birth defect/genetic 
disorder and POP controls. Adjusted mean differences in 2D:4D were − 1.82 and − 1.83 for 
left- and right-hand analyses, respectively. We could not further analyze this ASD subgroup 
in the complete restricted sample. In left-hand analyses, we also observed notable mean 2D:
4D differences between the dysmorphic ASD and POP groups; however, although the mean 
difference remained elevated in the complete restricted sample adjusted analysis (− 1.53), it 
was no longer statistically significant (p = 0.065). The findings for dysmorphic ASD versus 
POP group comparisons were less clear-cut in analyses of right-hand 2D:4D. Additionally, 
while we initially observed significant differences in left- and right-hand 2D:4D between 
children with ASD + ID and POP controls, the findings were attenuated and no longer 
significant after adjustment.
Assessment of Females: ASD Group Versus POP Group
In contrast to males, females with ASD had slightly higher mean left-hand 2D:4D than 
female POP controls (Table 4). In the full sample, the unadjusted and adjusted differences 
were 0.31 and 0.76, with the adjusted difference close to being statistically significant. The 
differences were much greater in the complete restricted sample (1.16 unadjusted and 1.75 
adjusted) and were statistically significant. Conversely, case-control differences in right-
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hand 2D:4D were small and non-significant, both in the full and complete restricted samples 
of females.
Assessment of Females: ASD Subgroups Versus POP Group
Most of the findings from ASD subgroup assessments in females (Table 5) were comparable 
to those from the ASD versus POP assessments presented in Table 4. In the complete 
restricted sample, we observed statistically significant differences in mean left-hand 2D:4D 
between POP controls and (1) children with ASD + ID, (2) children with ASD but not ID, 
(3) children with ASD without a birth defect/ genetic disorder, and (4) children with non-
dysmorphic ASD. Right-hand mean 2D:4D was not significantly different between POP 
controls and any of the aforementioned groups.
Small sample sizes (n ≤ 6) precluded us from assessing differences between POP controls 
and either children with ASD + a birth defect/genetic disorder or children with dysmorphic 
ASD in the complete restricted sample. However, we observed very large differences (> 2.0) 
in both left- and right-hand 2D:4D between children with ASD + a birth defect/genetic 
disorder and POP controls in the full (not restricted) sample both before and after 
adjustment.
Discussion
Our findings of decreased right-hand 2D:4D in male children with ASD in comparison to 
male children from the general population are generally consistent with several previous 
investigations (Al-Zaid et al. 2015; Masuya et al. 2015; Krajmer et al. 2011; Noipayak 2009; 
Sugie et al. 2010; Milne et al. 2006; de Bruin et al. 2006; Manning et al. 2001). However, 
the magnitude of the difference we observed between cases and controls was smaller than 
past studies showing an inverse association. In the full sample of > 400 male cases and > 
400 male controls we detected a case-control difference of − 0.51. Other studies documented 
differences ranging from − 1.3 to − 8.0 (Al-Zaid et al. 2015; Masuya et al. 2015; Krajmer et 
al. 2011; Noipayak 2009; Sugie et al. 2010; Milne et al. 2006; de Bruin et al. 2006; Manning 
et al. 2001). One possible reason for the differing magnitudes of effect between our study 
and others is age at assessment. SEED includes very young children (ages 3–5 years), while 
the average ages of children in other studies of ASD and 2D:4D were older (see Teatero and 
Netley 2013 for a summary). Given that some studies indicate 2D:4D changes slightly as 
children age (Trivers et al. 2006), it is possible that 2D:4D differences between children with 
and without ASD become more evident at older ages. The SEED in-depth data collection of 
maternal and perinatal factors allowed us to examine the impact of many important potential 
confounders not previously studied. We found that our results for left-hand 2D:4D were 
stronger after sample restriction to children whose mothers did not smoke during pregnancy, 
which suggests that the effect of maternal smoking on fetal testosterone might have masked 
an association between ASD and 2D:4D. Nonetheless, the studies examining the association 
between maternal smoking and maternal testosterone levels or child 2D:4D report mixed 
results (Rizwan et al. 2007; Toriola et al. 2011; Velez et al. 2017) and in the current study, 
we also found that controlling for other confounders slightly attenuated associations initially 
observed.
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SEED also allowed us to assess case subgroups and these analyses were more instructive. 
The largest left- and right-hand 2D:4D differences were observed for cases with a clear or 
potential genetic link—those with a co-occurring diagnosis of a birth defect or genetic 
disorder and those who were classified as dysmorphic. Further, we observed only modest 
(non-significant) case-control difference in either left- or right-hand 2D:4D for male ASD 
cases without ID, without a birth defect or genetic disorder, or for males with non-
dysmorphic ASD. These findings were generally similar before or after adjustment and 
sample restriction.
Altogether these findings suggest that in males, while ASD is associated with lower 2D:4D, 
the association may be primarily explained by genetic and associated dysmorphology 
differences between cases and controls rather than indicating a causal association between 
ASD and fetal exposure to high concentrations of testosterone. Thus, the lower right-hand 
2D:4D observed in our male case sample does not necessarily support the EMB theory.
Even though previous studies document high levels of amniotic fluid testosterone levels in 
males (Baron-Cohen et al. 2015) who have gone on to develop ASD, the causal pathway has 
not been clearly established. For instance, the Baron-Cohen et al. 2015 study indicates ASD 
is associated with a range of steroidal hormones in addition to testosterone—including 
progesterone and cortisol. Thus, other potential mechanisms related to these steroid 
hormones should also be considered. Likewise, it has been postulated that rather than a 
direct testosterone effect, a common gene or set of genes might be involved in the control 
both brain development and organ-specific responses to androgen and estrogenic activity 
(Zheng and Cohn 2011). Finally, it is important to note that while previous studies of males 
have primarily indicated an inverse association between 2D:4D and ASD diagnosis, studies 
that specifically investigated empathizing and systemizing measures in neuro-typical 
populations have shown much weaker effects or no effects with 2D:4D (Teatero and Netley 
2013).
Although our finding of increased left-hand 2D:4D in females with ASD appears 
inconsistent with one previous study showing no association (Maysuya et al. 2015) and one 
previous study showing an association between ASD and right- but not left-hand 2D:4D 
(Bejerot et al. 2012), the direction and magnitude of the differences we observed in this 
study were nonetheless similar to non-statistically significant differences reported in the two 
other studies of females. As with our analyses of males, we observed the largest case-control 
differences after restricting the sample to children not exposed to other factors potentially 
linked to in utero hormonal concentrations. However, unlike the findings for males, the case-
control differences for females were positive and were strengthened by further confounder 
adjustment rather than attenuated. Additionally, unlike our findings in males, in females we 
observed significant case-control differences whether or not cases had co-occurring ID, a 
birth defect or genetic disorder, or were dysmorphic. Thus, the higher 2D:4D in female cases 
might represent an association between ASD and either decreased in utero testosterone 
concentrations, increased in utero estradiol concentrations, or both. We did not have data to 
further explore the underlying reasons for this finding. One possible area of interest is the 
role of endocrine disrupting chemicals, which are found in a wide array of food and 
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consumer products and pesticides, and have been linked to various neurodevelopmental 
outcomes and symptoms (Schug et al. 2015).
Our findings must be interpreted in the context of study limitations. SEED includes a sample 
of young children (3–5 years of age) and thus, if bone growth occurs in an asynchronous 
manner, 2D:4D might not be reflective of in utero hormonal exposures. However, 
associations between 2D:4D and amniotic testosterone and estradiol concentrations have 
been established in children as young as 2 years of age (Lutchmaya et al. 2004). Moreover, 
several previous studies showing an association between ASD and 2D:4D were based on 
samples of pre-pubescent children (Al-Zaid et al. 2015; Milne et al. 2006; Manning et al. 
2001) with a much wider age range than our sample. Our digit ratio measurements were not 
taken directly but rather were taken from hand scans. Previous studies that included 
validation components reported high concordance between 2D:4D measured directly and 
from hand scans (Barona et al. 2015; Manning et al. 2001). However, scans have been found 
to yield lower (more masculinized) ratios (Ribeiro et al. 2016). Presumably, this would 
impact cases and controls consistently, but we could not assess this. Due to resource 
limitations we were not able to collect and code dysmorphology data for the full POP 
sample or for most of the other (non-ASD) DD group. Additionally, because the DD group 
is a heterogeneous mix of multiple disabilities we did not assess this group in any of our 
analyses, which somewhat limits interpretation of the findings from ASD case subgroup 
analyses.
In contrast to many other ASD studies, SEED sought to enroll a diverse population-based 
sample by identifying potentially eligible case children from multiple clinical and education 
sources serving children throughout each site’s catchment area and identifying potential 
control children from birth certificate samples. One drawback to this approach is that 
numerous families targeted for potential recruitment could not be located or contacted. It is 
likely that many of these families were actually ineligible for inclusion since our a priori 
eligibility criteria required children to have current as well as birth residence in the study 
catchment area; four sites also required parents to be able to communicate well in English. 
Given the low response rate, selection bias should be considered. However, in a separate 
study (currently unpublished) we have conducted a detailed analysis to assess whether non-
response was likely to have resulted in selection bias by assessing various risk estimates 
using data from one site that had access to some data on all families initially invited. We 
found that while certain demographic factors were associated with non-response—younger 
maternal age, lower maternal education, Hispanic ethnicity—other perinatal factors such as 
preterm birth, birth order, and infertility disorders and treatments were not (unpublished 
data). We adjusted all analyses in the current study for maternal age and education and child 
race-ethnicity and we initially assessed all associations within demographic strata to ensure 
there were no effect modifications by these factors. We also conducted adjusted analyses in 
which we included numerous biological risk factors. We have no reason to believe that a 
child’s digit lengths or digit ratios in and of themselves would have affected a parent’s 
decision to participate in SEED.
Despite these limitations, SEED offers one of the largest and most diverse samples available 
to assess the association between ASD and 2D:4D. Moreover, it allowed for a much more 
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detailed analysis of this research question than any previous study. Our findings suggest that 
among males, there is a small inverse association between ASD and 2D:4D, but it may be 
explained by genetic factors, presumed related to the presence of known syndromes and 
birth defects or the increased prevalence of dysmorphic features generally in children with 
ASD. In females there appears to be a positive association between ASD and left-hand 2D:
4D, which is not explained by confounding by demographic factors or maternal and 
perinatal health-related exposures and is not limited to select subgroups of children with 
genetic syndromes or increased prevalence of dysmorphic features. Thus, the association in 
females may be indicative of an association between ASD and in utero hormonal exposures. 
However, the finding of high 2D:4D in females with ASD is in the opposite direction of 
what would be predicted based on EMB theory and findings from the literature on fetal 
testosterone. Further study to understand fetal hormonal effects on neurodevelopment is 
particularly needed among females.
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Table 1
Characteristics of cases and controls, study to explore early development
ASD (N = 599) % POP (N = 811) %
Child sex
  Male 81.30 53.14
  Female 18.70 46.86
Child race/ethnicity
  Non-Hispanic White 54.75 68.38
  Non-Hispanic Black 17.80 10.92
  Hispanic 13.39 11.17
  Asian 5.93 3.26
  Mixed 8.14 6.27
Age at hand scan (months)
  < 48 5.56 7.60
  48–59 37.54 32.88
  60+ 56.90 59.53
Maternal age at birth (years)
  ≤ 34 71.81 68.60
  35+ 28.19 31.40
Maternal education at birth (years)
  ≤ 15 48.41 33.83
  16+ 51.59 66.17
Birth order
  First birth 48.71 45.56
  Second birth or later 51.29 54.44
Gestational age
  Term 83.22 90.84
  Preterm (< 37 weeks) 16.78 9.16
Birth plurality
  Singleton 91.08 96.24
  Multiple birth 8.92 3.76
Any maternal infertility disorder diagnosed prior to index pregnancy
  Yes 20.45 14.95
  No 79.55 85.05
Any maternal use ovulation medications to help get pregnant
  Yes 9.94 9.28
  No 90.06 90.72
Any maternal use progesterone medications to help get pregnant or maintain pregnancy
  Yes 10.69 9.54
  No 89.31 90.46
Maternal pre-pregnancy BMI (kg/m2)
  < 25 56.33 64.40
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ASD (N = 599) % POP (N = 811) %
  25.0–29.9 25.67 21.85
  ≥ 30 18.00 13.75
Maternal prenatal smoking
  No 90.97 95.97
  Yes 9.03 4.03
ASD Autism spectrum disorder case group, POP population control group, BMI body mass index
Data excluded due to missing values for individual factors. Missing values were 0% for child sex, 1–5% for maternal age, maternal education, birth 
order, gestational age and birth plurality, and maternal pre-pregnancy BMI, and 6–9% for maternal infertility conditions, ovulation induction 
medications, progesterone medications, and smoking
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Table 2













Left hand, n = 910
  Total sample
    Unadjusted, n = 910 94.20 94.56 − 0.36 0.162
    Adjusteda, n = 842 93.47 93.68 − 0.21 0.422
  Restriction to subgroups (unadjusted)
    Term birth, n = 784 94.15 94.48 − 0.33 0.226
    Singleton birth, n = 831 94.08 94.47 − 0.39 0.144
    No pre-pregnancy maternal infertility disorders reported, n = 691 94.34 94.59 − 0.25 0.405
    No ovulation medications used by mother to help get pregnant, n = 749 94.27 94.52 − 0.25 0.363
    No maternal progesterone medications used by mother to help get or 
maintain pregnancy, n = 744
94.25 94.51 − 0.26 0.366
    No maternal smoking during pregnancy, n = 801 93.99 94.62 − 0.63 0.020
  Complete restricted sampleb
    Unadjusted, n = 503 94.01 94.51 − 0.50 0.148
    Adjusteda, n = 477 93.16 93.43 − 0.28 0.423
Right hand, n = 914
  Total sample
    Unadjusted, n = 914 94.08 94.58 − 0.51 0.033
    Adjusteda, n = 846 93.63 93.97 − 0.34 0.172
  Restriction to subgroups (unadjusted)
    Term birth, n = 786 94.04 94.59 − 0.55 0.033
    Singleton birth, n = 834 94.02 94.54 − 0.52 0.039
    No pre-pregnancy maternal infertility disorders reported, n = 696 94.12 94.57 − 0.45 0.098
    No ovulation medications used by mother to help get pregnant, n = 754 94.12 94.59 − 0.46 0.077
    No maternal progesterone medications used by mother to help get or 
maintain pregnancy, n = 749
94.11 94.54 − 0.43 0.100
    No maternal smoking during pregnancy, n = 806 93.90 94.64 − 0.73 0.004
Complete restricted sampleb
    Unadjusted, n = 507 93.96 94.60 − 0.64 0.044
    Adjusteda, n = 481 93.49 93.97 − 0.48 0.145
Statistically significant findings are indicated in bold
ASD autism spectrum disorder case group, POP population control group
a
Adjusted models included child race-ethnicity, child age at scan, birth order, maternal age at birth, maternal education at birth and maternal 
prepregnancy body mass index
b
Complete restricted sample was restricted to children born in singleton term births with no pre-pregnancy maternal infertility disorders, no use of 
maternal ovulation medications or progesterone, and no maternal smoking during pregnancy
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Left hand, n = 489
  Total sample
    Unadjusted, n = 489 94.90 94.59 0.31 0.422
    Adjusteda, n = 460 94.41 93.65 0.76 0.056
  Restriction to subgroups (unadjusted)
    Term birth, n = 437 95.00 94.54 0.46 0.266
    Singleton birth, n = 458 94.81 94.59 0.22 0.587
    No pre-pregnancy maternal infertility disorders reported, n = 366 95.52 94.70 0.82 0.074
    No ovulation medications used by mother to help get pregnant, n = 404 95.26 94.76 0.50 0.242
    No maternal progesterone medications used by mother to help get or 
maintain pregnancy, n = 404
95.25 94.70 0.55 0.206
    No maternal smoking during pregnancy, n = 430 94.88 94.53 0.35 0.410
  Complete restricted sampleb
    Unadjusted, n = 271 95.61 94.45 1.16 0.049
    Adjusteda, n = 259 95.28 93.53 1.75 0.006
Right hand, n = 489
  Total sample
    Unadjusted, n = 489 95.01 94.87 0.14 0.720
    Adjusteda, n = 461 94.51 93.92 0.59 0.153
  Restriction to subgroups (unadjusted)
    Term birth, n = 438 95.10 94.79 0.31 0.468
    Singleton birth, n = 460 94.70 94.85 − 0.15 0.710
    No maternal infertility disorders reported, n = 367 95.16 94.99 0.17 0.720
    No ovulation medications used by mother to help get pregnant, n = 406 95.18 95.00 0.18 0.685
    No maternal progesterone medications used by mother to help get or 
maintain pregnancy, n = 406
94.98 94.95 0.03 0.941
    No maternal smoking during pregnancy, n = 431 94.73 94.88 − 0.15 0.728
  Complete restricted sampleb
    Unadjusted, n = 272 94.54 94.76 − 0.22 0.709
    Adjusteda, n = 260 94.08 93.91 0.17 0.791
Statistically significant findings are indicated in bold
ASD autism spectrum disorder case group, POP population control group
a
Adjusted models included child race-ethnicity, child age at scan, birth order, maternal age at birth, maternal education at birth and maternal 
prepregnancy body mass index
b
Complete restricted sample was restricted to children born in singleton term births with no pre-pregnancy maternal infertility disorders, no use of 
maternal ovulation medications or progesterone, and no maternal smoking during pregnancy
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